Jim Cramer’s Week Ahead: 17 Stocks in Focus, Including Alphabet and Bloom Energy

Page 4 of 11

13. Eli Lilly and Company (NYSE:LLY)

Eli Lilly and Company (NYSE:LLY) was on Jim Cramer’s Mad Money game plan for the week ahead. Noting that there is controversy around the company recently, Cramer said:

Now, this one’s a little controversial, Eli Lilly. They announced some scripts for the new weight loss drug, and they were disappointing. I admit that. Stock sold off big. I say, calm down. Lilly will tell a good story when it reports on Thursday morning. They’ve got a… little longer-term view than just 10 days.

Eli Lilly and Company (NYSE:LLY) develops and markets medicines for diabetes, obesity, oncology, immunology, neuroscience, and other chronic conditions. When a caller asked if the stock is a buy, sell, or hold on March 18, Cramer replied:

Okay, everybody’s giving up on Lilly. My experience with Eli Lilly is there are bouts of giving up in this. That’s what I call it, giving up in this. We’re in a giving up in this moment for one of the greatest, if not the greatest, drug company in history. I think the pill is going to be gigantic. People are saying that the… GLP is not big, okay? Not as big as we thought… What can I say? Buy Eli Lilly.

Page 4 of 11